Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

300 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Litigation in Ophthalmology against the National Health Service in England.
Kirthi V, Neffendorf JE, Navaratnam AV, Machin JT, Hingorani M, Briggs TWR, Davis A, MacEwen C, Jackson TL. Kirthi V, et al. Among authors: jackson tl. Ophthalmology. 2021 Oct;128(10):1487-1489. doi: 10.1016/j.ophtha.2021.03.028. Epub 2021 Mar 23. Ophthalmology. 2021. PMID: 33766572 Free article. No abstract available.
Subretinal Visual Implant Alpha IMS--Clinical trial interim report.
Stingl K, Bartz-Schmidt KU, Besch D, Chee CK, Cottriall CL, Gekeler F, Groppe M, Jackson TL, MacLaren RE, Koitschev A, Kusnyerik A, Neffendorf J, Nemeth J, Naeem MA, Peters T, Ramsden JD, Sachs H, Simpson A, Singh MS, Wilhelm B, Wong D, Zrenner E. Stingl K, et al. Among authors: jackson tl. Vision Res. 2015 Jun;111(Pt B):149-60. doi: 10.1016/j.visres.2015.03.001. Epub 2015 Mar 23. Vision Res. 2015. PMID: 25812924 Free article. Clinical Trial.
Epimacular Brachytherapy for Previously Treated Neovascular Age-Related Macular Degeneration (MERLOT): A Phase 3 Randomized Controlled Trial.
Jackson TL, Desai R, Simpson A, Neffendorf JE, Petrarca R, Smith K, Wittes J, Lewis C, Membrey L, Haynes R, Costen M, Steel DH, Muldrew A, Chakravarthy U; Macular Epiretinal Brachytherapy versus Ranibizumab (Lucentis) Only Treatment (MERLOT) Study Group. Jackson TL, et al. Ophthalmology. 2016 Jun;123(6):1287-96. doi: 10.1016/j.ophtha.2016.02.028. Epub 2016 Apr 13. Ophthalmology. 2016. PMID: 27086023 Free article. Clinical Trial.
300 results